Table of Contents

Ensuring medicines are released only into markets where they meet regulatory requirements is a critical compliance function.

But it can also be a complex and time-intensive process. Varying regional mandates, inconsistent approval timelines, and disconnected manual workflows can artificially extend the final release cycle by days or weeks, increasing carrying costs and deferring revenue.

Efficient market authorization requires simple coordination across many teams and systems. Jurisdictional control functionality in Veeva Batch Release automates the market authorization process while ensuring compliance, saving batch release teams time and cost.

How it works

Veeva Batch Release references data from Veeva Registrations to verify that all materials, manufacturing sites, processes, and suppliers used in a finished product batch meet each market-specific requirement. It also uses change control data from Veeva QMS to determine if any pending batch changes affect registration status or release eligibility.

QMS-Registrations to Batch Release process

Benefits for batch release teams

This fully connected approach automates and accelerates the market ship decision by embedding regulatory compliance checks directly into batch release workflows, giving disposition owners real-time knowledge of when a batch can be released to a market.

Key benefits include:

  • Immediate visibility into batches affected by open regulatory changes
  • Reduced manual effort with automatic assessment of market compliance
  • Minimized risk of non-compliant product release through proactive alerts

Jurisdictional Control example

For more on information on jurisdictional control visit this blog.